Platz KP - Search Results

1

Treatment of osteoporosis after liver transplantation.

Neuhaus R, Lohmann R, Platz KP, Guckelberger O, Schön M, Lang M, Hierholzer J, Neuhaus P. Neuhaus R, et al. Among authors: platz kp. Transplant Proc. 1995 Feb;27(1):1226-7. Transplant Proc. 1995. PMID: 7878857 Clinical Trial. No abstract available.

2

Influence of immunosuppression on patient survival after liver transplantation for hepatitis C.

Mueller AR, Platz K, Willimski C, Berg T, Steinmüller T, Neumann U, Neuhaus R, Hopf U, Radke C, Neuhaus P. Mueller AR, et al. Transplant Proc. 2001 Feb-Mar;33(1-2):1347-9. doi: 10.1016/s0041-1345(00)02504-5. Transplant Proc. 2001. PMID: 11267321 No abstract available.

3

Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506.

Mueller AR, Platz KP, Bechstein WO, Schattenfroh N, Stoltenburg-Didinger G, Blumhardt G, Christe W, Neuhaus P. Mueller AR, et al. Among authors: platz kp. Transplantation. 1994 Jul 27;58(2):155-70. Transplantation. 1994. PMID: 7518974 Clinical Trial.

4

Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506.

Platz KP, Mueller AR, Blumhardt G, Bachmann S, Bechstein WO, Kahl A, Neuhaus P. Platz KP, et al. Transplantation. 1994 Jul 27;58(2):170-8. Transplantation. 1994. PMID: 7518975 Clinical Trial.

5

Severe neurotoxicity after liver transplantation: association between FK 506 therapy and hepatitis C virus disease.

Mueller AR, Platz KP, Christe W, Bechstein WO, Blumhardt G, Neuhaus P. Mueller AR, et al. Among authors: platz kp. Transplant Proc. 1994 Dec;26(6):3131-2. Transplant Proc. 1994. PMID: 7527951 Clinical Trial. No abstract available.

6

Causes of death following liver transplantation in FK 506- and cyclosporine-treated patients.

Platz KP, Mueller AR, Bechstein WO, Blumhardt G, Neuhaus P. Platz KP, et al. Transplant Proc. 1994 Dec;26(6):3133-4. Transplant Proc. 1994. PMID: 7527952 Clinical Trial. No abstract available.

7

Increased rejection after liver transplantation in FK 506-treated patients is associated with viral hepatitis C disease.

Mueller AR, Platz KP, Bechstein WO, Blumhardt G, Lobeck H, Hop U, Neuhaus P. Mueller AR, et al. Among authors: platz kp. Transplant Proc. 1994 Dec;26(6):3637-9. Transplant Proc. 1994. PMID: 7527984 No abstract available.

8

Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience.

Neuhaus P, Blumhardt G, Bechstein WO, Platz KP, Jonas S, Mueller AR, Langrehr JM, Lohmann R, Schattenfroh N, Knoop M, et al. Neuhaus P, et al. Among authors: platz kp. Transplantation. 1995 Jan 15;59(1):31-40. doi: 10.1097/00007890-199501150-00007. Transplantation. 1995. PMID: 7530868 Clinical Trial.

9

Liver transplantation in hepatitis B surface antigen positive patients with postoperative long-term immunoprophylaxis.

Langrehr JM, Lemmens HP, Keck H, Lohmann R, Knoop M, Neumann U, Müller AR, Platz KP, Kling N, Hopf U, et al. Langrehr JM, et al. Among authors: platz kp. Transplant Proc. 1995 Feb;27(1):1215-6. Transplant Proc. 1995. PMID: 7533373 No abstract available.

10

Incidence of biliary complications following side-to-side choledochocholedochostomy after liver transplantation.

Keck H, Langrehr JM, Blumhardt G, Müller AR, Knoop M, Platz KP, Lohmann R, Bechstein WO, Neuhaus P. Keck H, et al. Among authors: platz kp. Transplant Proc. 1994 Dec;26(6):3544-5. Transplant Proc. 1994. PMID: 7998269 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters